An Experimental Study to Evaluate Hypolipidemic Effect of Terminalia arjuna on High Fat Diet Induced Dyslipidaemia in Wistar Rat

R. Nath
{"title":"An Experimental Study to Evaluate Hypolipidemic Effect of Terminalia arjuna on High Fat Diet Induced Dyslipidaemia in Wistar Rat","authors":"R. Nath","doi":"10.19080/crdoj.2021.14.555882","DOIUrl":null,"url":null,"abstract":"Introduction: Hyperlipidaemia is a well-established cardiovascular disease risk factor. Different medications are used to regulate dyslipidaemia. Efficacy and safety are questionable on treatment with lipid lowering drug for long period. Need of time is to search for new lead compound from phytoconstituents of plants which is equal in potency and efficacy with present oral hypolipidemic drug but with fewer side effects. Terminalia arjuna has hypolipidemic properties therefore this research is designed to evaluate the hypolipidemic effect of Terminalia arjuna on high-fat diet induced dyslipidaemia in Wistar rats. Methods: An experimental study was done. Total 36 Wistar rats divided into 6 group randomly. Group I given normal pellet diet. In remaining group dyslipidaemia induced by high fat diet given for four weeks. Group II (dyslipidaemia control) was given high fat diet. Group III, IV were given Terminalia arjuna 250 and 500mg/kg per oral and group V, VI were given Rosuvastatin 10mg/kg and 20mg/kg per oral for 8weeks. Blood samples withdrawn by retro-orbital puncture and analysed for total cholesterol, triglycerides, HDL by commercial kits. LDL, VLDL calculated by friedewald formula. ANOVA followed by post hoc analysis used for statistical analysis. Results: Terminalia arjuna showed reduction of total cholesterol, triglycerides, VLDL, LDL level at both doses and intergroup comparison were found to be statistically significant (p<0.05) at end of treatment. The change with Terminalia arjuna(500mg/kg) in total cholesterol, triglycerides, VLDL, LDL was comparable with Rosuvastatin(10mg/kg). Conclusion: Terminalia arjuna has substantial Hypolipidemic activity as it decreases total cholesterol, triglycerides, VLDL, LDL in dyslipidaemia rat thus it has promising role in treatment of hyperlipidaemia.","PeriodicalId":92021,"journal":{"name":"Current research in diabetes & obesity journal","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current research in diabetes & obesity journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19080/crdoj.2021.14.555882","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Hyperlipidaemia is a well-established cardiovascular disease risk factor. Different medications are used to regulate dyslipidaemia. Efficacy and safety are questionable on treatment with lipid lowering drug for long period. Need of time is to search for new lead compound from phytoconstituents of plants which is equal in potency and efficacy with present oral hypolipidemic drug but with fewer side effects. Terminalia arjuna has hypolipidemic properties therefore this research is designed to evaluate the hypolipidemic effect of Terminalia arjuna on high-fat diet induced dyslipidaemia in Wistar rats. Methods: An experimental study was done. Total 36 Wistar rats divided into 6 group randomly. Group I given normal pellet diet. In remaining group dyslipidaemia induced by high fat diet given for four weeks. Group II (dyslipidaemia control) was given high fat diet. Group III, IV were given Terminalia arjuna 250 and 500mg/kg per oral and group V, VI were given Rosuvastatin 10mg/kg and 20mg/kg per oral for 8weeks. Blood samples withdrawn by retro-orbital puncture and analysed for total cholesterol, triglycerides, HDL by commercial kits. LDL, VLDL calculated by friedewald formula. ANOVA followed by post hoc analysis used for statistical analysis. Results: Terminalia arjuna showed reduction of total cholesterol, triglycerides, VLDL, LDL level at both doses and intergroup comparison were found to be statistically significant (p<0.05) at end of treatment. The change with Terminalia arjuna(500mg/kg) in total cholesterol, triglycerides, VLDL, LDL was comparable with Rosuvastatin(10mg/kg). Conclusion: Terminalia arjuna has substantial Hypolipidemic activity as it decreases total cholesterol, triglycerides, VLDL, LDL in dyslipidaemia rat thus it has promising role in treatment of hyperlipidaemia.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
紫苏对高脂饮食诱导的Wistar大鼠血脂异常影响的实验研究
简介:高脂血症是公认的心血管疾病危险因素。不同的药物被用来调节血脂异常。长期服用降脂药的疗效和安全性值得怀疑。从植物的植物成分中寻找与现有口服降血脂药物效价和疗效相等但副作用小的新的先导化合物需要时间。阿尔终草具有降血脂作用,本研究旨在评价阿尔终草对高脂饮食诱导的Wistar大鼠血脂异常的降血脂作用。方法:进行实验研究。36只Wistar大鼠随机分为6组。第一组给予正常颗粒饲料。其余组为高脂饮食引起的血脂异常,给药4周。II组(血脂异常对照组)给予高脂饮食。III组、IV组给予阿尔朱终250、500mg/kg /次口服,V组、VI组给予瑞舒伐他汀10mg/kg、20mg/kg /次口服,连续8周。经眶后穿刺取血,用商用试剂盒分析总胆固醇、甘油三酯、高密度脂蛋白。LDL, VLDL由弗里德瓦尔德公式计算。方差分析后采用事后分析进行统计分析。结果:在治疗结束时,两剂量和组间比较,终叶总胆固醇、甘油三酯、VLDL、LDL水平均有显著降低(p<0.05)。与瑞舒伐他汀(10mg/kg)相比,终叶(500mg/kg)对总胆固醇、甘油三酯、VLDL、LDL的影响相当。结论:终叶具有较强的降血脂活性,可降低血脂异常大鼠的总胆固醇、甘油三酯、VLDL、LDL,对治疗高脂血症有较好的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Structure-Based Virtual Screening for Differential Inhibition of Aldose Reductase, Implicated in Secondary Complications in Diabetes Comparing Anxiety and Professional Efficiency Among Normal- and Over -Weight Medical Staff During the Covid-19 Outbreak: A Case-Control Study Can Alcohol and Obesity be Considered Risk Factors for Diabetes Mellitus? (environmental study) The Association Between Body Mass Index and Glycemic Control in Patients with Type 2 Diabetes Across Eight Countries: A Literature Review Implication of Mode of Consumption of Allium cepa L. (Onion) on Lipoglycemic and Anthropometric Impacts in Diabetic Rats: A Function of Choice
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1